Jump to main content
Jump to site search

Issue 27, 2013
Previous Article Next Article

Azastilbenes: a cut-off to p38 MAPK inhibitors

Author affiliations


Inhibitors with vicinal 4-fluorophenyl/4-pyridine rings on a five- or six-membered heterocyclic ring are known to inhibit the p38 mitogen-activated protein kinase (MAPK), which is a potential target for rheumatoid arthritis and several different types of cancer. Several substituted azastilbene-based compounds with vicinal 4-fluorophenyl/4-pyridine rings were designed using computational docking, synthesized, and evaluated in a cell-free radiometric p38α assay. The biochemical evaluation shows that the best inhibition (down to 110 nM) is achieved for azastilbene-based compounds having an isopropylamine substituent in the 2-position of the pyridine ring. The inhibition of p38 signaling in human breast cancer cells was observed for two of the compounds.

Graphical abstract: Azastilbenes: a cut-off to p38 MAPK inhibitors

Back to tab navigation

Supplementary files

Article information

18 Dec 2012
14 May 2013
First published
14 May 2013

Org. Biomol. Chem., 2013,11, 4526-4536
Article type

Azastilbenes: a cut-off to p38 MAPK inhibitors

J. Poon, J. P. Alao, P. Sunnerhagen and P. Dinér, Org. Biomol. Chem., 2013, 11, 4526
DOI: 10.1039/C3OB27449G

Social activity

Search articles by author